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Improvement of Oncolytic Adenovirus Vectors  
through Genetic Capsid Modifications
1. The capsid protein IX of human adenovirus type 5 (HAdV-5) is a suitable locale 
for the attachment of tumor targeting polypeptides.  (This thesis)
2. HAdV-5 can be targeted to cancer-testis antigens presented on tumor cells by 
incorporating single-chain T cell receptors in the viral capsid. (This thesis)
3. The attachment of a tumor targeting polypeptide to protein IX of HAdV-5 results 
in targeted transduction of tumor cells with varying efficiencies, depending on 
the polypeptide fused. (This thesis)
4. The absence of protein IX in the virus capsid results in enhanced activation of 
peripheral blood mononuclear cells, which suggests a biological function of 
protein IX in diminishing the immune response against HAdV-5. (This thesis)
5. Oncolytic vectors based on blood-borne virus types may display improved 
systemic delivery to tumor sites as compared to adenoviral vectors which 
require complex modifications to prevent rapid clearance from the circulation.
6. Preclinical studies with oncolytic viruses in animal models can be misleading 
as a result of differences in the anatomy or physiology between humans and 
animals.
7. Advances in our understanding of the molecular genetics of cancer suggest 
that the complexity of the heterogeneity of human malignancy both between 
patients with one disease type arising at a particular site as well as between 
cancer cells within one patient, is such that population-based unselected 
approaches have major limitations for the development of novel cancer 
therapeutics. J.S. de Bono and Alan Ashworth (Nature 2010; 467:543-549).
8. The recognition that oncolytic viruses can induce anti-tumor immune responses 
allows renaming of these therapeutic agents as ‘therapeutic vaccines’, which 
may facilitate their public acceptance and translation to the clinic.
9. Where all is but dream, reasoning and arguments are of no use, truth and 
knowledge nothing. John Locke (1632-1704).
10. It is the weight, not numbers of experiments that is to be regarded. Sir Isaac 
Newton (1643-1727).
11. We reveal ourselves in the metaphors we choose for depicting the cosmos in 
miniature. Steven Jay Gould, Full House: The Spread of Excellence from Plato 
to Darwin (New York: Three Rivers Press, 1996; 7).
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